A HPLC radiometric assay to quantitate flunisolide metabolites in body fluids. 1981

N I Chu, and P J Teitelbaum, and M D Chaplin

UI MeSH Term Description Entries
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005446 Fluocinolone Acetonide A glucocorticoid derivative used topically in the treatment of various skin disorders. It is usually employed as a cream, gel, lotion, or ointment. It has also been used topically in the treatment of inflammatory eye, ear, and nose disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732) Fluortriamcinolone Acetonide,Alvadermo,Capex,Co-Fluocin,Cortiespec,Derma-Smooth FS,Flucinar,Fluocid,Fluodermo,Fluonid,Fluotrex,Flurosyn,Flusolgen,Gelidina,Jellin,Jellisoft,Synalar,Synalar-HP,Synamol,Synemol,Acetonide, Fluocinolone,Acetonide, Fluortriamcinolone,Co Fluocin,Derma Smooth FS,Synalar HP
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

N I Chu, and P J Teitelbaum, and M D Chaplin
April 2004, Journal of pharmaceutical and biomedical analysis,
N I Chu, and P J Teitelbaum, and M D Chaplin
December 1995, Journal of pharmaceutical and biomedical analysis,
N I Chu, and P J Teitelbaum, and M D Chaplin
September 1988, Annals of clinical biochemistry,
N I Chu, and P J Teitelbaum, and M D Chaplin
April 1989, Analytical biochemistry,
N I Chu, and P J Teitelbaum, and M D Chaplin
July 1978, Journal of pharmaceutical sciences,
N I Chu, and P J Teitelbaum, and M D Chaplin
January 1991, Advances in experimental medicine and biology,
N I Chu, and P J Teitelbaum, and M D Chaplin
September 1988, DNA (Mary Ann Liebert, Inc.),
N I Chu, and P J Teitelbaum, and M D Chaplin
July 1991, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
N I Chu, and P J Teitelbaum, and M D Chaplin
June 1986, Biomedical chromatography : BMC,
N I Chu, and P J Teitelbaum, and M D Chaplin
December 1977, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!